Glickman notes
doi: 10.1016/j.cis.2013.10.008
Real-world retrospective analysis of data from the Barbara Davis Center compared type 1 diabetes patients on semaglutide and tirzepatide off-label over one year: 9.1% vs 21.4% body weight reduction and HbA1c reductions of 0.54% vs 0.68%, respectively [12]
Studies including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have demonstrated reduced cardiovascular events in patients with type 2 diabetes
The actual peptide content, purity, and handling conditions during shipping are unknown
According to recent studies, vegetarian and vegan diets can be successfully used in FM management [22], as plant-based diets have a positive anti-inflammatory effect on gut microbiome and, in general, help resist systemic inflammation [23]